FGF2 and breast carcinoma: Consistent results were also obtained from MDA-MB-231 breast cancer cells with endogenous FGFR1 protein expression, in which the bFGF-induced FOXQ1 mRNA and protein expression can be blocked by MEK/ERK inhibitors but not by AKT inhibitors (Fig. 3c and d).